News
A security guard who was convicted of fatally shooting a customer outside a 7-Eleven convenience store in Las Vegas five ...
A new COVID-19 variant named "Nimbus" has been detected in the U.S. and is spreading rapidly. Here's what to know about ...
The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one ...
1h
Tribune Online on MSNHow COVID-19 research is revolutionising understanding of brain health —Kelechi Elechi, Nigerian translational scientistKelechi Wisdom Elechi is a doctoral researcher specialising in ageing neurodegenerative diseases. With a background in pharmacy, his research focuses on the intersection of COVID-19, neurodegeneration ...
Moderna, Inc., a leader in the creation of the field of mRNA medicine, announced that the US Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ...
A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...
Explore more
Coronavirus cases may surge in the coming weeks, as they have every summer since the pandemic began five years ago, experts ...
South Africa’s health ministry has expressed concern about a persistent campaign of Covid-19 vaccine disinformation ...
Italian authorities have arrested a Chinese man accused by US prosecutors of being part of a hacking team that stole coveted ...
Scientists say the current COVID vaccine is effective against the Nimbus variant and is considered a “variant under ...
The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
Scientists are currently studying how well people are protected against severe disease from XFG. Researchers conducted lab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results